Nika Pharmaceuticals, Inc.
NIKA
$0.25
-$0.05-16.67%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.00K | 18.40K | 12.90K | 12.50K | 8.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.00K | 18.40K | 12.90K | 12.50K | 8.40K |
| Operating Income | -8.00K | -18.40K | -12.90K | -12.50K | -8.40K |
| Income Before Tax | -8.00K | -18.40K | -12.90K | -12.50K | -8.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.00K | -18.40K | -12.90K | -12.50K | -8.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.00K | -18.40K | -12.90K | -12.50K | -8.40K |
| EBIT | -8.00K | -18.40K | -12.90K | -12.50K | -8.40K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.04B | 1.03B | 1.03B | 1.03B | 1.02B |
| Average Diluted Shares Outstanding | 1.04B | 1.03B | 1.03B | 1.03B | 1.02B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |